PANcreatic CAncer Initial Detection via liquid biopsy

We’re looking forward to PANCAID’s 3rd General Assembly Meeting later this week in Brussels, Belgium! 🇧🇪

The meeting is a key moment for all partners to come together, review our progress, and plan the next steps in our mission to improve early detection of pancreatic cancer.

We’ll kick off with a Stakeholder Event at the European Parliament, bringing together key policymakers, patients and experts to discuss the importance of joint efforts on early detection of pancreatic cancer.

We look forward to seeing you soon!

As the year comes to a close, let’s take a moment to reflect on our achievements of 2024. This year has been one of progress, collaboration, and impactful work in the journey against pancreatic cancer. Here are some of the highlights:

Four Scientific Review Articles Published

PANCAID published four comprehensive review articles in renowned journals, covering topics:

• The potential of multibiomarker panels in liquid biopsies for early pancreatic cancer detection.
• The importance of economic evaluations in pancreatic cancer screening.
• Insights from screening high-risk populations and how this informs approaches for the general population.
• The role of incidental findings in pancreatic cancer diagnosis and how liquid biopsy could revolutionize the field.

Our Video Series: Raising Awareness

We launched a video series to make complex information about pancreatic cancer and the project accessible to a broader audience. From explaining “What is pancreatic cancer?” to discussing Liquid Biopsy, these videos are to help spread awareness about this challenging disease.

Collaborative Efforts

2024 was also a year of collaboration. From exploring opportunities for joint dissemination activities with other Horizon Europe projects to everyday collaboration with our partners, these partnerships strengthen our mission and amplify the impact of our work.

As we look ahead to 2025, we are filled with gratitude for the support and engagement of our community, partners, and followers. Together, we are making strides toward a future where pancreatic cancer can be detected earlier and treated more effectively. PANCAID wishes each and everyone a wonderful holiday season and a successful start to the new year.

We’re excited to announce the Save-the-Date for PANCAID’s first Stakeholder Dialogue Event!
When? 15th January 2025
Where? Brussels, Belgium
This event is a collaboration between PANCAID, Pancreatic Cancer Europe (PCE), and United European Gastroenterology (UEG)!